Author:
Gryka Rebecca J.,Buckley Leo F.,Anderson Sarah M.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. World Health Organization. The atlas of heart disease and stroke. 2014. http://www.who.int/cardiovascular_diseases/resources/atlas/en/ . Accessed 26 May 2014.
2. Cho JR, Rollini F, Franchi F, et al. Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar. Vasc Health Risk Manag. 2014;10:177–88.
3. Versteeg HH, Heemskerk JWM, Levi M, et al. New fundamentals in hemostasis. Physiol Rev. 2013;93:327–58.
4. Tricoci P, Huang Z, Held C, et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med. 2011;366(1):20–33.
5. Morrow DA, Braunwald E, Bonaca MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012;366(15):1404–13.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献